We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $259M
1-Year Est. Return 63.6%
This Fund
S&P 500
This Quarter Est. Return
+12.28%
1 Year Est. Return
+63.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$95.4M
AUM Growth
+$4.56M
Cap. Flow
-$5.67M
Cap. Flow %
-5.94%
Top 10 Hldgs %
60.09%
Holding
44
New
2
Increased
2
Reduced
25
Closed
1

Top Buys

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$2.08M
2
OXY icon
Occidental Petroleum
OXY
+$1.77M
3
CTVA icon
Corteva
CTVA
+$205K
4
IP icon
International Paper
IP
+$29.9K

Top Sells

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$1.72M
2
DD icon
DuPont de Nemours
DD
+$1.13M
3
MSFT icon
Microsoft
MSFT
+$903K
4
OIH icon
VanEck Oil Services ETF
OIH
+$669K
5
HES
Hess
HES
+$504K

Sector Composition

Rank Sector Weight
1 Healthcare 24.82%
2 Technology 20.67%
3 Communication Services 11.03%
4 Materials 8.92%
5 Energy 8.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
1
CVS Health
CVS
$139B
$7.44M 7.8%
100,120
-6,850
-6% -$481K
AAPL icon
2
Apple
AAPL
$4.78T
$6.99M 7.33%
95,268
-7,600
-7% -$489K
HES
3
DELISTED
Hess
HES
$6.04M 6.33%
90,343
-7,700
-8% -$504K
CI icon
4
Cigna
CI
$76.9B
$5.89M 6.17%
28,790
-2,500
-8% -$458K
MSFT icon
5
Microsoft
MSFT
$2.89T
$5.79M 6.07%
36,698
-6,150
-14% -$903K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$4.24T
$5.44M 5.7%
81,240
-6,000
-7% -$387K
IP icon
7
International Paper
IP
$19.9B
$5.21M 5.46%
119,486
+712
+0.6% +$29.9K
C icon
8
Citigroup
C
$224B
$5.19M 5.44%
65,015
-4,060
-6% -$300K
QCOM icon
9
Qualcomm
QCOM
$187B
$4.77M 5%
54,040
-3,800
-7% -$318K
CMCSA icon
10
Comcast
CMCSA
$85.3B
$4.57M 4.79%
101,665
-7,500
-7% -$334K
MOS icon
11
The Mosaic Company
MOS
$7.25B
$3.99M 4.19%
184,500
-86,800
-32% -$1.72M
BG icon
12
Bunge Global
BG
$24B
$3.73M 3.91%
64,875
-4,500
-6% -$249K
ABBV icon
13
AbbVie
ABBV
$454B
$3.08M 3.22%
34,735
-2,250
-6% -$187K
GDX icon
14
VanEck Gold Miners ETF
GDX
$23.7B
$2.92M 3.06%
99,610
-9,000
-8% -$246K
MDT icon
15
Medtronic
MDT
$105B
$2.74M 2.87%
24,127
-1,800
-7% -$198K
AGN
16
DELISTED
Allergan plc
AGN
$2.23M 2.34%
11,665
-700
-6% -$126K
UAL icon
17
United Airlines
UAL
$38.3B
$2.14M 2.24%
24,290
-2,000
-8% -$180K
NTR icon
18
Nutrien
NTR
$32.9B
$2.06M 2.16%
+43,000
New +$2.08M
PFE icon
19
Pfizer
PFE
$143B
$2.02M 2.11%
54,266
-4,111
-7% -$146K
DAL icon
20
Delta Air Lines
DAL
$55.4B
$2.02M 2.11%
34,457
-3,100
-8% -$174K
OXY icon
21
Occidental Petroleum
OXY
$57.2B
$1.82M 1.9%
+44,100
New +$1.77M
CSCO icon
22
Cisco
CSCO
$445B
$1.55M 1.62%
32,285
-3,500
-10% -$163K
DOW icon
23
Dow Inc
DOW
$22.6B
$1.16M 1.21%
21,137
-1,466
-6% -$75.7K
JPM icon
24
JPMorgan Chase
JPM
$926B
$892K 0.93%
6,400
-1,300
-17% -$167K
CTVA icon
25
Corteva
CTVA
$58.8B
$775K 0.81%
26,214
+7,727
+42% +$205K

Similar funds

Colrain Capital's Q4 2019 Portfolio in Review

As of Q4 2019, Colrain Capital held 44 positions worth $95.4M, up 5% from $90.9M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Colrain Capital withdrew a net $5.67M in Q4 2019, closing 1 position and reducing 25 holdings. Its most notable exit was MACOM Technology Solutions, an estimated $59K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 24% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Colrain Capital opened a new position in Nutrien worth $2.06M.

  • Colrain Capital's largest Q4 2019 buy was Nutrien: 43,000 shares worth $2.06M.
  • Colrain Capital added most to Corteva in Q4 2019, an estimated $205K increase.
  • Colrain Capital's biggest Q4 2019 reduction was The Mosaic Company, cutting an estimated $1.72M.
  • Colrain Capital fully exited MACOM Technology Solutions in Q4 2019, selling an estimated $59K.
  • Colrain Capital's ten largest holdings make up 60% of its $95.4M portfolio in Q4 2019.
  • Colrain Capital opened 2 new positions and closed 1 in Q4 2019.
  • Colrain Capital's portfolio value rose 5% quarter-over-quarter to $95.4M.

Based on Colrain Capital's 13F filing for Q4 2019, filed 30 Jan 2020.